F1000Research (Oct 2023)
Evaluation of comparative efficacy of cow milk treated Sida Cordifolia oil nasal administration (Ksheerbala Taila Nasya) versus Convolvulus pluricaulis oil nasal administration (Shankapushpi Taila Nasya) in the management of primary insomnia (Anidra)- a trial protocol [version 1; peer review: 2 approved]
Abstract
Background: Ayurveda, formerly known as the "Science of Life," is a distinct science and philosophy that aims to achieve comprehensive wellbeing by balancing the psychological, emotional, spiritual, and physical facets of life. The three basic principles listed by Ayurveda to maintain good health are Food (Ahara), sleep (Nindra), and Celibacy (Bramhacharya). According to Ayurveda, it is a strong rigid support of life. Many people today depend on sleeping pills and have developed a dependence on them. Potentially harmful side effects of sleeping drugs include drowsiness during the day, constipation, dizziness, and problems maintaining equilibrium. It is said that a vitiated Vata Dosha sets off the effects of insomnia, hence balancing Vata Dosha can provide relief in the event of Insomnia. Convolvulus Pluricaulis (Shankhpushpi) herb is a memory enhancer that can also be used as a brain tonic to stimulate brain and brain function. According to Ayurveda, the entrance to the brain is through the nose. Nasal administration refers to the practice of administering medication nasally. It is the most important therapy to treat upper clavicular disease. Objective: To study the evaluation of comparative efficacy of cow milk treated sida cordifolia oil nasal administration (Ksheerbala Taila Nasya) versus Convolvulus Pluricaulis Oil Nasal Administration (Shankapushpi Taila Nasya) in the Management of Primary Insomnia (Anidra)-RCT Protocol: In this study, a total of 128 patients will be divided into two groups. In group, A (64 patient) cow milk treated with Sida Cordifoila Oil Nasal Administration will be administered eight drops in each nostril for 15 days. The same will be used for the other 64 patients i.e., group B with Convolvulus Pluricaulis Oil Nasal Administration. Expected result: The result will be assessed on the objective parameter and data will be compared after the treatment.
